Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
批准号:
10617066
负责人:
Shruti H Mehta
金额:
$43.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-06-01 至 2028-05-31
中文摘要
项目摘要/摘要
这项提案是对为期5年的国家研究服务奖11-15年的续展申请
机构研究补助金,以支持艾滋病毒流行病学和预防科学的培训计划
约翰霍普金斯大学彭博公共卫生学院和约翰霍普金斯大学医学院
(SOM),题为“约翰·霍普金斯大学艾滋病毒流行病学和预防科学培训计划”。这个
该项目将由Shruti Mehta博士领导,他是公共卫生硕士,过去一直担任该项目的副主任
十年了。我们正在请求支持3名博士后和4名博士后实习生,该计划的任务是培训
博士后学生和博士后研究员将成为最优先关注的艾滋病毒领域的领导者
在三个培训轨道上拥有高级能力和最新技能的研究:1)艾滋病毒流行病学
和实施科学方法,包括(1)人口和研究设计方面的培训,包括
确定、招募和留住与国内和国际艾滋病毒研究相关的人群以及
实施科学的当代设计;(2)感染和感染的人群中的测量问题
艾滋病毒风险,包括监测的创新方法、以人口为基础的疾病负担衡量和
MHealth/在线数据收集战略;(3)推理技术,包括因果推理、数学
建立模型;(4)综合研究结果并将其付诸实践,包括系统审查,
成本效益分析和艾滋病毒方案实施的障碍;2)艾滋病毒临床和实验室
科学包括以下方面的培训:(1)流行病学、预防和管理重大混合感染
艾滋病毒,包括丙型肝炎病毒感染、结核病和SARS-CoV-2/新冠肺炎;
艾滋病毒的发病机制和与年龄相关的共病;以及(3)测量和使用(例如,系统动力学)
遗传、病毒学和免疫学因素,这些因素可以帮助我们了解发病机制和
艾滋病毒的传播;和3)艾滋病毒预防科学,包括如何预防和减少流行率和
通过培训感染艾滋病毒(1)设计和分析艾滋病毒生物医学、行为和综合
预防试验战略,包括作为预防研究的治疗(TasP)、PrEP、艾滋病毒疫苗和
被动免疫治疗试验,以及(2)以社区为基础的人群一级艾滋病毒预防和治疗方法
控制力。我们的计划通过JHU艾滋病研究中心(CFAR)完全整合在一起
为艾滋病毒工作的受训者创造了一个丰富和互动的环境,特别是
由流行病学、临床、预防和合作开展的创新、富有成效和协作的艾滋病毒研究
约翰霍普金斯大学BSPH和SOM的实施科学家。
英文摘要
PROJECT SUMMARY / ABSTRACT
This proposal is a renewal application for years 11-15 of a 5-year National Research Service Award
Institutional Research Grant to support a training program in HIV Epidemiology and Prevention Sciences at
the Johns Hopkins Bloomberg School of Public Health (BSPH) and the Johns Hopkins School of Medicine
(SOM), entitled the “Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program.” The
program will be led by Shruti Mehta PhD, MPH who has been the deputy director of this program for the past
10 years. We are requesting support for 3 pre- and 4 post-doctoral trainees The program mission is to train
pre-doctoral students and post-doctoral fellows to become leaders at the forefront of highest priority HIV
research with advanced competencies and state-of-the-art skills in three training tracks: 1) HIV Epidemiology
and Implementation Science Methods including training in (1) Populations and Study Designs, including
identifying, recruiting, and retaining populations relevant for domestic and international HIV research as well as
contemporary designs for implementation science; (2) Measurement issues in populations infected with and at
risk for HIV, including innovative methods for surveillance, population-based measures of disease burden and
mHealth/online strategies for data collection; (3) Inference techniques, including causal inference, mathematical
modeling; and (4) Synthesis and Implementation of research findings to practice, including systematic reviews,
cost-effectiveness analyses, and barriers to implementation of HIV programs; 2) HIV Clinical and Laboratory
Sciences including training in (1) the epidemiology, prevention and management of major co- infections with
HIV including hepatitis C virus (HCV) infection, tuberculosis and SARS-CoV-2/COVID-19; (2) epidemiology and
pathogenesis of HIV and age-associated co-morbidities; and (3) Measurement and use (e.g., phylodynamics)
of genetic, virologic and immunologic factors that can inform our knowledge of the pathogenesis and
transmission of HIV; and 3) HIV Prevention Sciences including how to prevent and reduce the prevalence and
incidence of HIV through training in (1) Design and Analysis of HIV biomedical, behavioral and integrated
strategies for prevention trials, including treatment as prevention research (TasP), PrEP, HIV vaccine and
passive immune-therapy trials, and (2) Community-based population-level approaches to HIV prevention and
control. Our program, which is fully integrated through the JHU Center for AIDS Research (CFAR) has
resulted in a rich and interactive environment for trainees working in HIV augmented by the exceptionally
innovative, productive and collaborative HIV research conducted by epidemiological, clinical, prevention and
implementation scientists throughout Johns Hopkins BSPH, and SOM.
期刊论文(137)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Transactional Sex and Incident Chlamydia and Gonorrhea Among Black Men Who Have Sex With Men in Atlanta, Georgia.
佐治亚州亚特兰大男男性行为黑人中的性交易和衣原体和淋病事件。
DOI:
10.1097/olq.0000000000001168
发表时间:
2020
期刊:
Sexually transmitted diseases
影响因子:
3.1
作者:
[Rucinski,KatherineB, Eaton,LisaA, Learner,EmilyR, Watson,RyanJ, Maksut,JessicaL, Earnshaw,ValerieA]
通讯作者:
Earnshaw,ValerieA
DOI:
10.15585/mmwr.mm7135e1
发表时间:
2022-09-02
期刊:
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
影响因子:
33.9
作者:
[Delaney, Kevin P., Sanchez, Travis, Hannah, Marissa, Edwards, O. Winslow, Carpino, Thomas, Agnew-Brune, Christine, Renfro, Kaytlin, Kachur, Rachel, Carnes, Neal, DiNenno, Elizabeth A., Lansky, Amy, Ethier, Kathleen, Sullivan, Patrick, Baral, Stefan, Oster, Alexandra M.]
通讯作者:
Oster, Alexandra M.
The Relationship Between Sexual Behavior Stigma and Depression Among Men Who have Sex with Men and Transgender Women in Kigali, Rwanda: a Cross-sectional Study.
卢旺达基加利与男性发生性关系的男性与跨性别女性的性行为污名与抑郁症之间的关系:一项横断面研究。
DOI:
10.1007/s11469-021-00699-5
发表时间:
2022-12
期刊:
INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION
影响因子:
8
作者:
[Okonkwo, Nneoma, Rwema, Jean Olivier Twahirwa, Lyons, Carrie, Liestman, Benjamin, Nyombayire, Julien, Olawore, Oluwasolape, Nsanzimana, Sabin, Mugwaneza, Placidie, Kagaba, Aflodis, Sullivan, Patrick, Allen, Susan, Karita, Etienne, Baral, Stefan]
通讯作者:
Baral, Stefan
Branched sexuality and sexual health among Black cisgender sexual minority men in Baltimore, Maryland: an exploratory study.
马里兰州巴尔的摩黑人顺性别性少数男性的性行为和性健康分支:一项探索性研究。
DOI:
10.1080/13691058.2022.2096260
发表时间:
2023
期刊:
Culture, health & sexuality
影响因子:
--
作者:
[Wiginton,JohnMark, Tobin,Karin, Maksut,Jessica, Davey-Rothwell,Melissa, Latkin,Carl]
通讯作者:
Latkin,Carl
DOI:
10.1002/jia2.25604
发表时间:
2020-10
期刊:
Journal of the International AIDS Society
影响因子:
6
作者:
[Twahirwa Rwema JO, Lyons CE, Herbst S, Liestman B, Nyombayire J, Ketende S, Mazzei A, Olawore O, Nsanzimana S, Mugwaneza P, Kagaba A, Sullivan PS, Allen S, Karita E, Baral SD]
通讯作者:
Baral SD
共 84 条
Integrating HCV services into HIV programs for PWID in India
-
批准号:10651729
-
项目类别:
-
资助金额:$90.71万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
-
批准号:10319551
-
项目类别:
-
资助金额:$68.78万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Elimination of HCV and related liver disease among HIV-infected and -uninfected people who inject drugs
-
批准号:10543537
-
项目类别:
-
资助金额:$68.76万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Integrating HCV services into HIV programs for PWID in India
-
批准号:9974478
-
项目类别:
-
资助金额:$112.39万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Integrating HCV services into HIV programs for PWID in India
-
批准号:10210233
-
项目类别:
-
资助金额:$114.42万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Integrating HCV services into HIV programs for PWID in India
-
批准号:10433886
-
项目类别:
-
资助金额:$106.17万
-
财政年份:2019
-
负责人:Shruti H Mehta
-
依托单位:
Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program
-
批准号:10401811
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2013
-
负责人:Shruti H Mehta
-
依托单位:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
-
批准号:8535239
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2010
-
负责人:Shruti H Mehta
-
依托单位:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
-
批准号:8133094
-
项目类别:
-
资助金额:$58.09万
-
财政年份:2010
-
负责人:Shruti H Mehta
-
依托单位:
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
-
批准号:8713968
-
项目类别:
-
资助金额:$54.46万
-
财政年份:2010
-
负责人:Shruti H Mehta
-
依托单位:
HEPATITIS C INFECTION & DIABETES IN INJECTION DRUG USERS
-
批准号:6515415
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2002
-
负责人:Shruti H Mehta
-
依托单位:
HEPATITIS C INFECTION & DIABETES IN INJECTION DRUG USERS
-
批准号:6378462
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2001
-
负责人:Shruti H Mehta
-
依托单位:
HEPATITIS C INFECTION & DIABETES IN INJECTION DRUG USERS
-
批准号:6134763
-
项目类别:
-
资助金额:$3.47万
-
财政年份:2000
-
负责人:Shruti H Mehta
-
依托单位:
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
-
批准号:6736968
-
项目类别:
-
资助金额:$59.6万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
-
批准号:6946361
-
项目类别:
-
资助金额:$59.19万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
-
批准号:8678881
-
项目类别:
-
资助金额:$114.22万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
-
批准号:7115850
-
项目类别:
-
资助金额:$61.06万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
Incidence of HIV Infection in a Cohort of IV Drug Users
-
批准号:8212290
-
项目类别:
-
资助金额:$100.21万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
Incidence of HIV Infection in a Cohort of IV Drug Users
-
批准号:7766613
-
项目类别:
-
资助金额:$2.28万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
-
批准号:7122174
-
项目类别:
-
资助金额:$5.96万
-
财政年份:1999
-
负责人:Shruti H Mehta
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:尹富君
-
依托单位:
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
-
批准号:2026JJ81995
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:田中秋
-
依托单位:
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
-
批准号:2026JJ81281
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐艳
-
依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究
-
批准号:JCZRQNB202600778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIV相关血管早衰的免疫炎症机制及基于循环生物标志物的风险评估模型构建
-
批准号:2026JJ80647
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:关艳丽
-
依托单位:
基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
-
批准号:2026JJ81431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏友
-
依托单位:
基于NASBA-侧向层析联用的HIV-1 RNA检测方法构建及其扩增-识别耦合机制研究
-
批准号:JCZRLH202601701
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIV-1低病毒血症患者储存库活性与耐药突变评价体系的临床应用研究
-
批准号:2026JJ30181
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈钟
-
依托单位:
HIV介导树突状细胞线粒体损伤通过PD-L1通路促进潜伏结核激活的机制研究
-
批准号:2026JJ82503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李榜龙
-
依托单位:
基于分子-社会网络的成渝地区MSM人群HIV感染风险识别及协同管理机
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:谭天宇
-
依托单位: